secwatch.observer — SEC 8-K summary
======================================

Issuer:     Amneal Pharmaceuticals, Inc. (AMRX)
CIK:        0001723128
Form:       8-K
Filed at:   2022-08-03T23:59:59+00:00
Accession:  0001193125-22-210639
Event type: leadership
Sentiment:  neutral
Materiality: 0.40
Item codes: 5.02, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Amneal appoints Deborah M. Autor to Board of Directors, effective July 29, 2022
-------------------------------------------------------------------------------

- Deborah M. Autor appointed independent director; will serve on Conflicts Committee.
- Autor previously FDA Deputy Commissioner and Global Head at AstraZeneca and Mylan.
- Board now comprises 11 directors following her appointment.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1723128/000119312522210639/0001193125-22-210639-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1723128/000119312522210639/d384456d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-22-210639

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer